Skip to main content
    I

    IQVIA Holdings Inc (IQV)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $271.15
    +9.14 (+3.49%)

    Market Cap: $43.12B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +1.71%
    Streak
    38 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$3.27
    Range$3.22 - $3.54
    19 analysts
    EPS Revisions
    10
    0
    7d
    10
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$3.25+0.6%
    60d ago$3.27+0.0%
    30d ago$3.27+0.0%
    7d ago$3.27+0.0%
    Current$3.27
    Revenue Consensus
    $4.4B
    Range$4.3B - $4.4B
    16 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.84
    Range$3.75 - $4.26
    22 analysts
    Revenue Consensus
    $4.6B
    Range$4.6B - $4.8B
    20 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.84---
    Sep 26EST
    		-$3.27---
    Jun 26
    Reported Jul 28
    		$2.75$2.72+1.10%Beat-2.1%
    Mar 26
    Reported May 5
    		$2.90$2.82+2.84%Beat+7.4%
    Dec 25
    Reported Feb 5
    		$3.42$3.40+0.59%Beat+9.6%
    Sep 25
    Reported Oct 28
    		$3.00$2.98+0.67%Beat+5.6%
    Jun 25
    Reported Jul 22
    		$2.81$2.77+1.44%Beat+6.4%
    Mar 25
    Reported May 6
    		$2.70$2.63+2.66%Beat+6.3%
    Dec 24
    Reported Feb 6
    		$3.12$3.11+0.32%Beat+9.9%
    Sep 24
    Reported Oct 31
    		$2.84$2.81+1.07%Beat+14.1%
    Jun 24
    Reported Jul 22
    		$2.64$2.56+3.13%Beat+8.6%
    Mar 24
    Reported May 2
    		$2.54$2.48+2.42%Beat+3.7%
    Dec 23
    Reported Feb 14
    		$2.84$2.82+0.71%Beat+2.2%
    Sep 23
    Reported Nov 1
    		$2.49$2.45+1.63%Beat+0.4%
    Jun 23
    Reported Aug 1
    		$2.43$2.37+2.53%Beat-0.4%
    Mar 23
    Reported Apr 27
    		$2.45$2.41+1.66%Beat-0.8%
    Dec 22
    Reported Feb 10
    		$2.78$2.76+0.72%Beat+9.0%
    Sep 22
    Reported Oct 26
    		$2.48$2.38+4.20%Beat+14.3%
    Jun 22
    Reported Jul 21
    		$2.44$2.38+2.52%Beat+14.6%
    Mar 22
    Reported Apr 27
    		$2.47$2.42+2.07%Beat+13.3%
    Dec 21
    Reported Feb 15
    		$2.55$2.43+4.94%Beat+20.9%
    Sep 21
    Reported Oct 21
    		$2.17$2.12+2.36%Beat+33.1%
    Jun 21
    Reported Jul 27
    		$2.13$2.08+2.40%Beat+80.5%
    Mar 21
    Reported Apr 22
    		$2.18$1.86+17.20%Beat+45.3%
    Dec 20
    Reported Feb 10
    		$2.11$2.00+5.50%Beat+21.3%
    Sep 20
    Reported Oct 20
    		$1.63$1.54+5.84%Beat+1.9%
    Jun 20
    Reported Jul 22
    		$1.18$1.06+11.32%Beat-22.9%
    Mar 20
    Reported Apr 28
    		$1.50$1.48+1.35%Beat-2.0%
    Dec 19
    Reported Feb 12
    		$1.74$1.72+1.16%Beat+16.0%
    Sep 19
    Reported Oct 30
    		$1.60$1.57+1.91%Beat+12.7%
    Jun 19
    Reported Jul 24
    		$1.53$1.49+2.68%Beat+18.6%
    Mar 19
    Reported May 1
    		$1.53$1.51+1.32%Beat+14.2%
    Dec 18
    Reported Feb 14
    		$1.50$1.47+2.04%Beat+7.1%
    Sep 18
    Reported Oct 22
    		$1.42$1.39+2.16%Beat+19.3%
    Jun 18
    Reported Jul 24
    		$1.29$1.23+4.88%Beat+18.3%
    Mar 18
    Reported May 2
    		$1.34$1.27+5.51%Beat+32.7%
    Dec 17
    Reported Feb 14
    		$1.40$1.34+4.48%Beat+204.3%
    Sep 17
    Reported Oct 26
    		$1.19$1.14+4.39%Beat-
    Jun 17
    Reported Aug 3
    		$1.09$1.05+3.81%Beat-
    Mar 17
    Reported May 3
    		$1.01$0.96+5.21%Beat-
    Dec 16
    Reported Feb 14
    		$0.46N/A-56.19%Miss-

    Key Metrics

    Valuation
    P/E Ratio22.46EV/EBITDA16.82x
    Price/FCF20.62xFCF Yield4.85%
    Profitability
    Profit Margin8.10%Operating Margin13.00%
    ROE22.80%ROIC8.73%
    Financial Health
    Debt/Equity2.59xInterest Coverage2.98x
    Current Ratio0.71xQuick Ratio0.71x
    Trading Statistics
    Beta1.17Avg Volume1.56M
    52-Week High$277.4052-Week Low$154.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$261.72
    SMA 20$265.32
    SMA 50$259.33
    SMA 200$207.55
    EMA 10$263.63
    EMA 20$263.44
    EMA 50$254.47
    EMA 200$218.07

    MACD

    Line: 1.12Signal: 1.63Hist: -0.51

    ADX

    ADX: 21.0+DI: 25.9-DI: 15.3

    Aroon & PSAR

    Aroon Up36.0
    Aroon DownN/A
    PSAR$252.56

    Bollinger Bands

    Upper Band$275.87
    Lower Band$254.77
    %B Position795%(Upper)
    Band Width0.78

    RSI (14-Day)

    Neutral
    60.1

    Momentum Oscillators

    Stoch %K53.7
    Stoch %D41.8
    Williams %R-14.4
    ROC (10d)4.0%
    Momentum10.43
    CCI (20d)44.0
    MFI (14d)56.2

    Volatility Measures

    ATR (14d)$7.31(2.7%)
    StdDev (20d)5.27
    Hist Vol26.6%(Moderate)

    Volume Flow

    VWAP$268.40
    OBV10.1M
    AD Line41.6M
    CMF (20d)-0.073

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio0.9x
    VWMA (20d)$265.87

    Pivot Points

    R3$271.35
    R2$269.01
    R1$265.51
    Pivot Point$263.16
    S1$259.66
    S2$257.32
    S3$253.82

    Advanced Oscillators

    TSI4.77
    Ultimate Osc53.5
    KST4.74

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$4.37B$4.15B$4.36B$4.10B$4.02B$3.83B$3.96B$3.90B$3.81B$3.74B$3.87B$3.74B
    Cost of Revenue$2.93B$2.80B$2.93B$2.73B$2.69B$2.53B$2.58B$2.52B$2.49B$2.44B$2.48B$2.43B
    Gross Profit$1.44B$1.35B$1.44B$1.37B$1.32B$1.30B$1.38B$1.38B$1.33B$1.29B$1.39B$1.31B
    Operating Expenses$929.00M$841.00M$809.00M$820.00M$817.00M$802.00M$752.00M$828.00M$806.00M$787.00M$889.00M$829.00M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$574.00M$502.00M$468.00M$514.00M$509.00M$508.00M$453.00M$522.00M$509.00M$508.00M$556.00M$502.00M
    Operating Income$506.00M$514.00M$627.00M$553.00M$506.00M$496.00M$626.00M$550.00M$520.00M$506.00M$501.00M$481.00M
    Interest Income$7.00M$10.00M$11.00M$13.00M$10.00M$11.00M$11.00M$13.00M$12.00M$11.00M$12.00M$14.00M
    Interest Expense$200.00M$192.00M$195.00M$189.00M$182.00M$169.00M$171.00M$170.00M$163.00M$166.00M$187.00M$181.00M
    Income Before Tax$301.00M$328.00M$537.00M$408.00M$323.00M$323.00M$544.00M$349.00M$436.00M$340.00M$373.00M$349.00M
    Income Tax Expense$60.00M$59.00M$59.00M$76.00M$56.00M$61.00M$112.00M$65.00M$75.00M$49.00M$-102,000,000$51.00M
    Net Income$258.00M$275.00M$514.00M$332.00M$266.00M$249.00M$437.00M$285.00M$363.00M$288.00M$469.00M$303.00M
    EBITDA$792.00M$804.00M$1.04B$876.00M$777.00M$751.00M$1.01B$789.00M$862.00M$764.00M$869.00M$818.00M
    EBIT$494.00M$510.00M$721.00M$584.00M$495.00M$481.00M$704.00M$506.00M$587.00M$495.00M$548.00M$516.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IQV

    News

    IQVIA: A $34.2 Billion Backlog Does Not Guarantee Faster Earnings Growth (NYSE:IQV)

    IQVIA Holdings reported strong Q2 2026 results with significant revenue growth and a 19% increase in R&D Solutions bookings, leading to a substantial $34.2 billion backlog. However...

    Seeking Alpha•10/16/26•Neutral

    Stifel lifts target for IQVIA Holdings stock to USD 303.00

    Stifel has increased its price target for IQVIA Holdings (IQV) stock to USD 303.00 from USD 276.00, maintaining a Buy rating. The stock's current NYSE price of USD 271.25 is near its 52-week high...

    ad-hoc-news.de•10/15/26•Bullish

    IQVIA Holdings Inc. stock outperforms competitors on strong trading day

    IQVIA Holdings Inc. (IQV) saw its stock rise by 3.45% to $271.04, outperforming the broader market during a strong trading session. The S&P 500 Index gained 0.33%...

    MarketWatch•10/15/26•Bullish

    Thermo Fisher Scientific (TMO) Expands Drug Development Services, Is The Stock Fully Valued?

    Thermo Fisher Scientific (TMO) is seeing increased demand for its drug development services, evidenced by a recent contract win for a Phase 2 multiple sclerosis trial. Despite strong share price momentum and positive...

    Simply Wall Street•10/15/26•Neutral

    Evercore Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $290

    Evercore has reiterated its Buy rating for IQVIA Holdings (IQV.US) and increased the target price to $290. This decision reflects the firm's continued confidence in IQVIA's financial performance and future prospects....

    Moomoo•10/14/26•Bullish

    IQV Valuation and Fair Value

    P/E
    22.5x
    Forward P/E
    18.4x
    EV/EBITDA
    16.8x
    P/FCF
    20.6x
    PEG
    1.0x
    P/B
    7.3x
    See GNG's fair value

    IQV Profitability: Margins, ROIC and FCF

    Gross margin
    33.0%
    Operating margin
    13.0%
    Net margin
    8.1%
    ROIC
    8.7%
    ROE
    22.8%
    FCF margin
    12.9%
    FCF yield
    4.8%

    IQV Competitors

    CompanyTicker
    Teva Pharma Industries Ltd ADRTEVA
    Waters CorporationWAT
    Veeva Systems Inc Class AVEEV
    Haleon plcHLN
    Agilent Technologies IncA
    Revolution Medicines IncRVMD
    Edwards Lifesciences CorpEW
    Illumina IncILMN

    Sector: Healthcare

    IQV Analyst Ratings

    Consensus
    Buy
    Analysts
    22
    Strong Buy
    3
    Buy
    16
    Hold
    3
    Sell
    0
    Strong Sell
    0

    IQV Bull Case vs Bear Case

    Bull case

    • IQV beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 86.4% of IQV's analyst ratings are Buy or Strong Buy.

    Bear case

    • IQV has a debt-to-equity ratio of 2.6x.

    IQV Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    1.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $3.27
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    10 up, 4 down

    Frequently Asked Questions About IQV

    Does IQV pay dividends?

    IQVIA Holdings Inc (IQV) does not currently pay a regular dividend.

    What is IQV's P/E ratio?

    IQVIA Holdings Inc has a price-to-earnings (P/E) ratio of 22.46.

    What is IQV's market cap?

    IQVIA Holdings Inc (IQV) has a market capitalization of $43.12B with a current stock price of $271.15.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In